Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2016 1
2017 1
2019 2
2021 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

4 results

Results by year

Filters applied: . Clear all
Page 1
Long-term visual acuity outcomes following cataract surgery in eyes with ocular inflammatory disease.
Gangaputra S, Newcomb C, Armour R, Choi D, Ying GS, Groth S, Begum H, Fitzgerald T, Artornsombudh P, Daniel E, Bhatt N, Foster S, Jabs D, Levy-Clarke G, Nussenblatt R, Rosenbaum JT, Sen HN, Suhler E, Thorne J, Dreger K, Buchanich J, Kempen JH; Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Research Group. Gangaputra S, et al. Br J Ophthalmol. 2024 Feb 21;108(3):380-385. doi: 10.1136/bjo-2022-322236. Br J Ophthalmol. 2024. PMID: 36810151
Visual Acuity Outcome over Time in Non-Infectious Uveitis.
Pistilli M, Joffe MM, Gangaputra SS, Pujari SS, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Sen HN, Suhler EB, Thorne JE, Bhatt NP, Foster CS, Begum H, Fitzgerald TD, Dreger KA, Altaweel MM, Holbrook JT, Kempen JH; Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Research Group. Pistilli M, et al. Ocul Immunol Inflamm. 2021 Aug 18;29(6):1064-1071. doi: 10.1080/09273948.2019.1687733. Epub 2019 Dec 10. Ocul Immunol Inflamm. 2021. PMID: 31821051 Free PMC article.
Remission of Intermediate Uveitis: Incidence and Predictive Factors.
Kempen JH, Gewaily DY, Newcomb CW, Liesegang TL, Kaçmaz RO, Levy-Clarke GA, Nussenblatt RB, Rosenbaum JT, Sen HN, Suhler EB, Thorne JE, Foster CS, Jabs DA, Payal A, Fitzgerald TD; Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Research Group. Kempen JH, et al. Am J Ophthalmol. 2016 Apr;164:110-7.e2. doi: 10.1016/j.ajo.2015.12.034. Epub 2016 Jan 6. Am J Ophthalmol. 2016. PMID: 26772874 Free PMC article.